Detalhe da pesquisa
1.
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
Int J Cancer
; 150(6): 1007-1017, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741530
2.
Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment.
Oncologist
; 25(9): e1406-e1413, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335971
3.
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
Clin Chem
; 66(12): 1510-1520, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257977
4.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487035
5.
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.
BMC Cancer
; 18(1): 51, 2018 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310623
6.
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis.
Support Care Cancer
; 26(1): 21-32, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28861627
7.
Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials.
Br J Cancer
; 117(12): 1768-1776, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123255
8.
Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.
Oncologist
; 22(2): 131-138, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28174294
9.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet Oncol
; 17(1): 57-66, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26655425
10.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662018
11.
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study.
BMC Cancer
; 16: 82, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865161
12.
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.
Support Care Cancer
; 24(5): 1941-1954, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476625
13.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Lancet Oncol
; 16(13): 1355-69, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361971
14.
CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.
BMC Cancer
; 15: 923, 2015 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589718
15.
Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort study.
Acta Oncol
; 54(2): 171-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307517
16.
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet
; 381(9873): 1203-10, 2013 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23433739
17.
IMWG consensus on maintenance therapy in multiple myeloma.
Blood
; 119(13): 3003-15, 2012 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22271445
18.
Trastuzumab in advanced breast cancer--a decade of experience in Germany.
BMC Cancer
; 14: 924, 2014 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487774
19.
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results.
BMC Cancer
; 14: 761, 2014 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311943
20.
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial.
Front Oncol
; 14: 1283266, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384801